Intrinsic Value of S&P & Nasdaq Contact Us

Arvinas, Inc. ARVN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
61/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.80
+7.3%

Stock Statistics — ARVN

Arvinas, Inc. (ARVN) has a market capitalization of $706.47M and trades at $11.00. The 52-week range is 5.9-14.51.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.6, Earnings Per Share (EPS) of $-1.28, annual revenue of $262.6M.

The stock has a beta of 1.98, operates in the Healthcare sector.

Trading Data
Current Price$11.00
52-Week Range5.9-14.51
Volume830.07K
Avg Volume (30D)928.75K
Market Cap$706.47M
Beta (1Y)1.98
Company
IPO Date2018-09-27
Employees430
CEORandy Teel
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS04335A1051
CUSIP04335A105
Income (Latest Year)
Revenue$262.6M
Gross Profit$257.4M
EBITDA$-75.3M
Operating Income$-114.9M
Net Income$-80.8M
EPS$-1.28
EPS Diluted$-1.28
Shares Outstanding$64.9M
Balance Sheet (Latest Year)
Total Assets$717.9M
Current Assets$700.7M
Cash & ST Investments$685.4M
Total Liabilities$284M
Total Debt$8.5M
Net Debt$-134.4M
Total Equity$433.9M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-8.6
P/S Ratio2.69
P/B Ratio1.63
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message